AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
InterCure and Cannasoul have signed a strategic investment and collaboration agreement to advance cannabis science and pharmaceutical innovation. The partnership combines InterCure's global pharmaceutical platform with Cannasoul's world-class analytics and scientific innovation. The collaboration comes as the Trump administration explores cannabis rescheduling, potentially unlocking opportunities for international operators like InterCure. InterCure will acquire a 28% ownership position in Cannasoul and has an exclusive path to increase its holdings to 51%.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet